Seven Mile Advisory’s Idexx Laboratories IDXX Stock Holding History

Seven Mile Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-419	Closed	-$283K	–	236
2025 Q4	$283K	Sell	419 -4	-0.9%	-$2.72K	0.05%	181
2025 Q3	$270K	Buy	+423	New	+$257K	0.04%	224

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seven Mile Advisory's IDXX Position: Q1 2026 in Review

Seven Mile Advisory sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 419 shares — an estimated $283K sold.

Seven Mile Advisory first reported a position in IDXX in Q3 2025 and held it in 2 quarters. The position peaked at $283K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Seven Mile Advisory reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Seven Mile Advisory sold 419 Idexx Laboratories shares in Q1 2026, an estimated $283K.
Seven Mile Advisory first reported a position in Idexx Laboratories in Q3 2025 and held it in 2 quarters.
Seven Mile Advisory's Idexx Laboratories position peaked at $283K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.